References
- Mantovani A, Dinarello CA, Ghezzi P. Pharmacology of Cytokines. New York: Oxford University Press, 2000.
- Levy JA. HIV and the Pathogenesis of AIDS, 2nd edn. American Society of Microbiology Press, 1998.
- Beauparlant P, Hiscott J. Biological and biological inhibitors of the NF-kB/Rel proteins and cytokine synthesis. Cytokine Growth Fac Rev 1996; 7: 175–90.
- Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956–9.
- Alcami J, Lain de Lera T, Folgueira L, et al. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 1995; 14: 1552–60.
- Jacque JM, Fernandez B, Arenzana-Seisdedos F, et al. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes. J Virol 1996; 70: 2930–8.
- Kopp EB, Ghosh S. NF-kappa B and rel proteins in innate immunity. Adv Immunol 1995; 58: 1–27.
- Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995; 9: 2723–35.
- Kotler DP, Reka S, Hecker L, Cohen S, Clayton F, Tierney AR. Treatment of HIV-associated mucosal inflammation with oral 5-ASA. Gastroenterology 1992; 102: 648A.
- Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acq Immun Defic Syndr Hum Retrovir 1997; 15: 370–4.
- Goodman & Gilman. The Pharmacological Basis of Therapeutics, 8th edn. New York: Pergamon, 1990.